IDEAYA Biosciences, Inc. (IDYA) vs Veracyte, Inc. (VCYT)

A side-by-side comparison of IDEAYA Biosciences, Inc. and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IDYA vs VCYT

growth of $100 · dividends reinvested · last 7y
IDYA +240.1% (+19.1%/yr)VCYT +97.1% (+10.2%/yr)IDYA compounded faster over this window
0100200300400Start $100202120232025$340$197
IDYA VCYT

IDYA vs VCYT: by the numbers

  • •VCYT is the larger company ($3.52B vs $3.47B market cap).
  • •VCYT is profitable (20.37% net margin) while IDYA runs a net loss (-74.75%).
  • •IDYA grew revenue faster over the past five years (45.80% vs 28.98% CAGR).

Metrics side by side

Valuation

MetricIDYAVCYT
P/E ratioN/A31.55
Forward P/EN/A23.08
P/S ratio14.806.27
P/B ratio2.892.54
EV / EBITDAN/A28.02
FCF yieldN/A4.69%

Profitability

MetricIDYAVCYT
Gross margin-43.89%72.09%
Operating margin-72.84%17.03%
Net margin-74.75%20.37%
ROE-14.60%8.25%
ROIC-17.68%6.72%

Growth (annualized)

MetricIDYAVCYT
Revenue CAGR (5Y)45.80%28.98%
Total return CAGR (5Y)7.32%1.45%

Frequently asked

Which has grown faster, IDYA or VCYT?
Over the past five years, IDYA grew revenue faster — IDYA at a 45.80% CAGR versus VCYT at 28.98%.
Is IDYA or VCYT more profitable?
VCYT runs the higher net margin — IDYA at -74.75% versus VCYT at 20.37%.
How have IDYA and VCYT total returns compared?
Over the past 5 years, IDYA delivered 7.32% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.